Institut Català d'Oncologia - Hospital Universitari de Girona
Girona 17007
0 studies enrolling now · 1 studies all time
What they study most
HNSCC
Studies at this site
Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC
— Completed